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Am J Physiol Gastrointest Liver Physiol 295: 338–347, 2008. First
published June 5, 2008; doi:10.1152/ajpgi.00514.2007.—The contribu-
tion of the liver to glucose utilization is essential to maintain glucose
homeostasis. Previous data from protein tyrosine phosphatase (PTP)
1B-deficient mice demonstrated that the liver is a major site for
PTP1B action in the periphery. In this study, we have investigated the
consequences of PTP1B deficiency in glucose uptake in hepatocytes
from neonatal and adult mice. The lack of PTP1B increased basal
glucose uptake in hepatocytes from neonatal (3–5 days old) but not
adult (10–12 wk old) mice. This occurs without changes in hexoki-
nase, glucokinase, and glucose 6-phosphatase enzymatic activities. By
contrast, the glucose transporter GLUT2 was upregulated at the
protein level in neonatal hepatocytes and livers from PTP1B-deficient
neonates. These results were accompanied by a significant increase in
the net free intrahepatic glucose levels in the livers of PTP1B/
neonates. The association between GLUT2 and insulin receptor (IR)
A isoform was increased in PTP1B/ neonatal hepatocytes com-
pared with the wild-type. Indeed, PTP1B deficiency in neonatal
hepatocytes shifted the ratio of isoforms A and B of the IR by
increasing the amount of IRA and decreasing IRB. Moreover, over-
expression of IRA in PTP1B/ neonatal hepatocytes increased the
amount of IRA/GLUT2 complexes. Conversely, hepatocytes from
adult mice only expressed IRB. Since IRA plays a direct role in the
regulation of glucose uptake in neonatal hepatocytes through its
specific association with GLUT2, we propose the increase in IRA/
GLUT2 complexes due to PTP1B deficiency as the molecular mech-
anism of the increased glucose uptake in the neonatal stage.
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TYPE 2 DIABETES MELLITUS is a polygenic disease affecting over
100 million people worldwide. Affected patients manifest
insulin resistance, hyperinsulinemia, and hyperglycemia (33).
Among the peripheral tissues involved in the control of glucose
homeostasis, the liver plays a major role because this organ has
the ability to consume and produce glucose. Accordingly,
deregulation between glucose uptake and production by the
liver is thought to contribute to the onset of type 2 diabetes (9).
It is now known that in the postprandial state the liver takes up
approximately one-third of an oral glucose load, which is
incorporated into glycogen and fatty acids or oxidized into CO2
(31, 32). Previous studies have demonstrated that under phys-
iological conditions a “portal signal” induced by the negative
arterial-portal glucose gradient seen with feeding creates an
important signal to enhance net hepatic glucose uptake
(NHGU) or hepatic glycogen deposition in rodents (8), dogs
(1), and humans (10). NHGU was increased by a rise in insulin
and further stimulated by the presence of a portal signal. Thus
NHGU is dependent on the amount of glucose reaching the
liver, the insulin level within the hepatic sinusoids, and a signal
generated by portal glucose delivery. Therefore, the roles of
hyperglycemia and hyperinsulinemia in regulating hepatic glu-
cose uptake have extensively been studied.
Among the animal models mimicking hepatic insulin resis-
tance, liver-specific insulin receptor knockout (LIRKO) mice
showed an impaired insulin tolerance and also a postprandial
hyperglycemia in the fed state. Euglycemic/hyperinsulinemic
clamps also revealed a significant decrease of total glucose
utilization in response to insulin in fed LIRKO mice compared
with their controls, an indication of insulin resistance (16). At
the molecular level, in a recent study in neonatal hepatocytes,
bearing or void of insulin receptor (IR), we have demonstrated
that IR plays a direct role in the regulation of basal glucose
uptake through its specific association with endogenous
(GLUT2), but not with exogenous (GLUT4), glucose trans-
porters (28).
Several mice models showing increased hepatic insulin sen-
sitivity phenotype have been reported. Among them, protein
tyrosine phosphatase (PTP)1B-deficient mice have revealed a
unique role of this phosphatase as a negative modulator of
insulin signaling and insulin action in the liver (13, 22, 25). In
fact, the suppression of hepatic glucose production (HGP) by
insulin is increased in 8–10-wk-old PTP1B-deficient mice (13,
22). However, we have recently shown that hepatic insulin
sensitization due to the lack of PTP1B is acquired during
postnatal development in mice since adult, but not neonatal,
PTP1B-deficient mouse hepatocytes showed increased insulin
signaling and a more pronounced inhibition of gluconeogenic
gene expression compared with the wild-type (20). Since no
data has been reported regarding the effect of PTP1B defi-
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ciency on glucose uptake in hepatocytes, the aim of this study
was to investigate whether or not PTP1B deficiency improves
glucose uptake in hepatocytes in the neonatal (3–5 days old) or
adult (8–12 wk old) postnatal developmental stages that dis-
play substantial differences in insulin sensitivity.
MATERIALS AND METHODS
Materials. Fetal calf serum and culture media were obtained from
Gibco (Gaithersburg, MD). The reagents for the measurement of
glucokinase (GK), hexokinase (HK), and glucose 6-phosphatase
(G6Pase) activities, insulin, hygromycin, puromycin, and monoclonal
anti--actin (clone AC-15, no. A5441) antibody were from Sigma
Chemical (St. Louis, MO). Protein A-agarose was from Roche Mo-
lecular Biochemicals (Mannheim, Germany). The anti-IR -subunit
(sc-711) and anti-GLUT2 (sc-9117) antibodies were purchased from
Santa Cruz Biotechnology (Palo Alto, CA). The anti-GLUT1 (Ref.
CBL 242) antibody was from Chemicon International (Temecula,
CA). The anti-GK antibody was a gift of J. J. Guinovart (Barcelona,
Spain). The antibody against IRB isoform (exon 11) was previously
described (38).
Primary culture of neonatal hepatocytes. PTP1B-deficient mice
(25) were obtained from Abbott Laboratories (Abbott Park, IL). All
animal studies were approved by the Consejo Superior de Investiga-
ciones Científicas (CSIC) Animal Care and Use Committee. Pools of
4–6 livers from wild-type (PTP1B/) and PTP1B/ neonates (3–5
days old) were submitted to collagenase dispersion and isolated as
previously described (15). Cells were plated in growing medium (199
MEM supplemented with 10% FBS, 25 ng/ml EGF, 0,1 M dexa-
methasone, and 50 nM insulin) and used for further experiments.
Immortalized neonatal hepatocyte cell lines. Viral BOSC 23 pack-
aging cells were transfected at 70% confluence with 3 g/6-cm dish
of the puromycin-resistance retroviral vector pBabe encoding SV40
Large T antigen (kindly provided by J. de Caprio, Dana Farber Cancer
Institute, Boston, MA) as previously described (41). Then, primary
neonatal hepatocytes were infected at 60% confluence with poly-
brene-supplemented virus (4 g/ml) for 48 h and maintained in
culture medium for 72 h before selection with puromycin (0, 5–1
g/ml) for 1 wk. Pools of infected cells rather than individual clones
were selected to avoid potential clone-to-clone variations. Immortal-
ized cell lines were further cultured for at least 2 wk with arginine-free
medium supplemented with 10% FBS and ornithine to avoid growth
of nonparenchymal cells. The experiments were performed in three
independent cell lines from each genotype obtained by immortaliza-
tion of three different preparations of neonatal hepatocytes.
Coding sequence for the human IR lacking exon 11 (isoform A)
cloned into pBabe-hygro retroviral vector was a gift of C. R. Kahn
(Joslin Diabetes Center, Boston, MA). Viral particles were obtained,
and PTP1B/ hepatocytes were infected with polybrene-supple-
mented (4 g/ml) virus for 48 h and then placed in selection medium
containing hygromycin (200 g/ml) for at least 2 wk. As a control,
PTP1B/ cells were infected with viral particles expressing empty
vector (pBabe hygro).
Immortalized neonatal hepatocytes expressing IRA or IRB iso-
forms have been previously described (28).
Primary culture of adult hepatocytes. Hepatocytes were isolated
from nonfasting male wild-type and PTP1B-deficient mice (10–12 wk
old) by perfusion with collagenase as described (4). Cells were plated
on 60-mm Primaria dishes (Falcon; BD Biosciences, San Jose, CA)
and cultured in Williams’ E medium supplemented with 20 ng/ml
EGF, 100 U/ml penicillin, 100 g/ml streptomycin, and 10% FBS for
48 h. Then, cells were serum starved and used for experiments.
Homogenization and preparation of tissue extracts. Frozen livers
were homogenized in 16 volumes (wt/vol) of ice-cold lysis buffer
containing 50 mM Tris HCl, 1% Triton X-100, 2 mM EGTA, 10 mM
EDTA acid, 100 mM NaF, 1 mM Na4P2O7, 2 mM Na3VO4, 100
g/ml phenylmethylsulfonyl fluoride, 1 g/ml aprotinin, 1 g/ml
pepstatin A, and 1 g/ml leupeptin, using the Brinkman PT 10/35
Polytron. Extracts were kept ice cold at all times. Liver extracts were
cleared by microcentrifugation at 15,000 g for 20 min at 4°C. The
supernatant was aliquoted and stored at 80°C.
Isolation of plasma membranes. Partially purified fractions of liver
plasma membranes were isolated following Hiol et al. (23), with
modifications. Livers were homogenized with buffer H (0.25 M
sucrose, 1 mM MgCl2, and 5 mM Tris HCl pH 7.4, containing
protease inhibitors). The homogenate underwent centrifugation at 300
g for 5 min, the supernatant was saved, and the pellet was homoge-
nized and centrifuged as above. The first and second supernatants
were combined and centrifuged at 1,500 g for 10 min. The pellet was
resuspended in buffer H and then buffer F (2 M sucrose, 1 mM
MgCl2, and 5 mM Tris HCl, pH 7.4) was added to obtain a final
sucrose concentration of 1.42 M. The suspension was transferred to a
nitrocellulose tube and overlaid with buffer H. The samples were then
centrifuged for 60 min at 120,000 g (Beckman SW-60 Ti rotor); the
pellicle at the interface was then collected, resuspended in buffer H,
and centrifuged for 10 min at 1,500 g. Finally, the pellet (plasma
membrane fraction) was resuspended in 20 mM EDTA, 1% Nonidet
P-40, and 50 mM Tris HCl pH 7.4.
Immunoprecipitations and Western blot. Quiescent cells (15 h
serum-starved) were lysed as previously described (20). After protein
content determination, equal amounts of protein (600 g-1 mg) were
immunoprecipitated at 4°C with the corresponding antibodies. The
immune complexes were collected on protein A-agarose beads and
submitted to SDS-PAGE. Proteins were transferred to Immobilon
membranes and incubated overnight with several antibodies as indi-
cated. Immunoreactive bands were visualized using the enhanced
chemiluminescence Western blotting protocol (Amersham, Piscat-
away, NJ).
Protein determination. Protein determination was performed by the
Bradford dye method (7) using the Bio-Rad (Hercules, CA) reagent
and BSA as the standard.
Measurement of glucose uptake. Hepatocytes were plated at high
density (60–70% confluence) and maintained in growing medium for
48 h. Cells were then cultured in serum-free medium for a further
15 h, and glucose uptake was measured as previously described (42).
Cells were washed three times with Krebs-Ringer-phosphate buffer
(KRP) containing 135 mM NaCl, 5.4 mM KCl, 1.4 mM CaCl2, 1.4
mM MgSO4, and 10 mM sodium pyrophosphate, pH 7.4, and then
incubated with 1 ml KRP buffer with or without insulin (10 nM) for
10 min at 37°C. 2-Deoxy-D[1-3H]glucose was added to this solution
to a final concentration of 0.1 mM and 250 nCi/ml, and the incubation
was continued for 10 min. The cells were then washed three times
with ice-cold KRP buffer and solubilized in 1 ml 1% SDS. The
radioactivity of a 200-l aliquot was determined in a scintillation
counter. After protein content determination, individual values were
expressed as picomoles of glucose per 10 min per milligrams protein,
and results were expressed as fold increase over basal wild-type cells.
Measurement of enzymatic activities. For enzymatic assays, liver
homogenates (10% wt/vol) were prepared in sucrose-Tris buffer (10
mM Tris HCl pH 7.4, 0.25 M sucrose, and 0.5 mM EDTA) at 4°C.
The homogenates were centrifuged at 12,000 g for 20 min, and the
resulting supernatants were centrifuged at 105,000 g for 45 min. The
supernatants were used for GK and HK assays, and the pellets
(microsomes) were used for the G6Pase determination. GK and HK
activities were measured by spectrophotometric assays in presence of
45 mM Tris HCl, pH 7.4, 110 mM KCl, 8 mM MgCl2, 0.5 mM
NADP, 5 mM ATP and 0.9 U/ml of glucose-6-phosphate (G6P)
dehydrogenase. Glucose (100 mM or 0.5 mM) was added for GK and
HK determination, respectively (35). G6Pase activity was measured
spectrophotometrically in the microsome fraction previously treated
with sodium deoxycholate. The assay is based in the Pi liberation from
G6P according to Zakko et al. (44).
Measurement of net free intrahepatic glucose. The freeze-clamped
livers were extracted with 4 volumes of ice-cold 6% (wt/vol) HClO4.
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The protein precipitates were removed by centrifugation at 10,000 g
for 10 min. The supernatant was neutralized with KOH. Glucose was
assayed by using a glucose oxidase method (40).
RNA isolation and quantitative real-time PCR analysis. Total RNA
was isolated with Trizol reagent (Invitrogen, Carlsbad, CA) and
reverse transcribed using the reverse transcription system kit (Pro-
mega, Madison, WI). PCR reactions were run in triplicate using
SYBR Green Master Mix Plus (Eurogentec, Seraing, Belgium) and
quantitated using the ABI Prism 7700 sequence detection system
(Applied Biosystems, Courtaboeuf, France) according to the manu-
facturer’s instructions. PCR primers for GLUT2 were described in
Ref. 26. Cycle threshold values were normalized to 18S rRNA, and
results were expressed as fold change of mRNA compared with the
wild-type condition, which was arbitrarily assigned a value of 1.
RNA extraction and Northern blot analysis. RNA was isolated from
livers of 3–5-day-old mice, and 20 g were submitted to Northern blot
analysis. Blots were hybridized with the cDNA probe for GLUT2.
Membranes were subjected to autoradiography, and the relative den-
sities of the hybridization signals were determined by densitometric
scanning of the autoradiograms.
Semi-quantitative RT-PCR. To analyze IR isoforms (IRA and IRB)
in neonatal and adult primary hepatocytes by PCR, 1 g of total RNA
was primed with oligodT (deoxythymidine) in the presence of murine
mammary tumor virus reverse transcriptase (Invitrogen) to synthesize
cDNA. The samples were diluted fivefold, and 5% of the total volume
was used for subsequent PCR. Primers used were the following:
mouse IR exon 11 primer 1, 5-ATCAGAGTGAGTATGACGACT-
CGG-3 and primer 2, 5-TCCTGACTTGTGGGCACAATGGTA-3;
human IR exon 11 primer 1, 5-ACCAGAGTGAGTATGAGGAT-
TCGG-3 and primer 2, 5-TCCGGACTCGTGGGCACGCTGG-
TC-3. For amplification of mouse -actin, the following primers
were used: primer 1, 5-GGTATGGAATCCTGTGGCATCCAT-
GAAA-3 and primer 2, 5- GTGTAAAACGCAGCTCAGTAA-
CAGTCC-3. PCR reactions were performed as described (14). Re-
action products were resolved on 2% agarose gels.
Statistical analysis. Experiments performed at least three times are
presented as mean values  SE. Comparisons among groups were
made using two-tailed Student’s t-test. Differences were considered
statistically significant at P  0.05.
RESULTS
Effect of PTP1B deficiency on glucose uptake in neonatal
and adult hepatocytes. Hepatic glucose uptake and utilization
is essential to maintaining whole body glucose homeostasis.
We investigated whether the lack of PTP1B leads to changes in
the rate of glucose entry in hepatocytes in a postnatal devel-
opmental manner. For this goal, we obtained primary hepa-
tocytes from 3–5-day-old and 10 –12-wk-old wild-type
(PTP1B/) and PTP1B-deficient (PTP1B/) mice that rep-
resent distant stages of postnatal development. Primary hepa-
tocytes were plated at high density (60–70% confluence) and
maintained in growing medium for 48 h. Cells were then
cultured in serum-free medium for a further 15 h, and glucose
uptake was measured after 10-min incubation in the presence
of 3H-2-deoxyglucose. As shown in Fig. 1A, the lack of PTP1B
increased by 50% basal glucose uptake in neonatal hepatocytes
compared with the corresponding wild-type controls. As ex-
pected, glucose uptake in neonatal hepatocytes was insulin
independent.
We have recently generated immortalized hepatocyte cell
lines from wild-type and PTP1B-deficient neonates (3–5 days
old) (20) that have been proven to be unique tools to study
insulin signaling and insulin actions due to the experimental
Fig. 1. Effect of protein tyrosine phosphatase (PTP)-1B
deficiency on glucose uptake in neonatal and adult
primary hepatocytes. Primary and immortalized neona-
tal (A) and primary adult (B) hepatocytes (obtained
from 3–5-day-old and 10–12-wk-old mice, respec-
tively) were cultured to confluence and then serum-
starved for 15 h. Then, cells were incubated with the
mix of 2-deoxy-D (1-3H)-glucose and cold glucose for
10 min. Glucose uptake was measured as described in
MATERIALS AND METHODS. Results are expressed as fold
increase over basal wild-type cells (set to 1) and are
means  SE from 3 independent experiments with
duplicate dishes. Statistical significance was carried out
by Student’s t-test by comparison of PTP1B/ with
PTP1B/ cells (*P  0.05).
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limitations of the primary cultures. Glucose uptake was mea-
sured in immortalized neonatal hepatocytes from both geno-
types under the same experimental conditions as in primary
cells. Figure 1A shows similar increases in immortalized hepa-
tocytes lacking PTP1B compared with the wild-type controls.
Interestingly, glucose uptake did not change between wild-type
and PTP1B/ primary hepatocytes from adult mice either in
the absence or presence of 10 nM insulin (Fig. 1B).
Effect of PTP1B deficiency in the endogenous expression of
GLUT2, GLUT1, and GK in neonatal and adult livers and
hepatocytes. Next, we analyzed the differential expression of
the ubiquitous glucose transporter GLUT1, the liver-specific
glucose transporter GLUT2, and the hepatic glucose sensor GK
in livers and primary hepatocytes from neonatal and adult mice
lacking PTP1B. Of note, primary hepatocytes were cultured
under the same experimental conditions as those used for the
functional experiments. Figure 2A shows that the expression of
GK was very low in neonatal livers and neonatal hepatocytes.
These results agree with those previously reported (6, 34).
Conversely, adult hepatocytes expressed high levels of GK,
with no differences found between both genotypes. The ex-
pression of GLUT1 was detectable but remained unchanged in
livers and primary hepatocytes from both neonatal and adult
PTP1B-deficient mice compared with their respective wild-
type controls. By contrast, GLUT2 was upregulated in liver
extracts, plasma membranes, and hepatocytes from neonatal,
but not adult, PTP1B-deficient mice (Fig. 2, A and B). To
determine whether transcriptional changes may explain the
differences observed in GLUT2, we examined transcript levels
in livers from 3–5-day-old mice by real-time PCR and North-
ern blot analysis. As shown in Fig. 2C, no differences were
found in GLUT2 expression at the mRNA level between
neonatal livers of both genotypes.
Effect of PTP1B deficiency on HK, GK, and G6Pase activ-
ities and net free intrahepatic glucose in livers of neonatal and
adult mice. Net hepatic glucose flux is the balance between the
rate of glucose phosphorylation catalyzed by GK and the rate
of dephosphorylation of G6P catalyzed by G6Pase. Impor-
tantly, in hepatocytes from suckling mice, constitutively ex-
pressed HK is the main enzyme responsible for glucose phos-
phorylation (6, 34). Next, we investigated whether changes in
the activities of HK and G6Pase could account for the net
Fig. 2. Effect of PTP1B levels in the endoge-
nous expression of glucose transporter 1
(GLUT1), GLUT2, and glucokinase (GK) in
livers and primary hepatocytes from neonatal
and adult wild-type and PTP1B-deficient mice.
A, left: whole cell lysates from neonatal and
adult primary hepatocytes and liver extracts
from 6–8 neonatal and adult mice of each ge-
notype were analyzed by SDS-PAGE followed
by Western blot with antibodies against GLUT1,
GLUT2, GK, and -actin as a loading control. A
representative experiment is shown. Right:
plasma membrane (PM) fraction was isolated
from neonatal livers, and the expression of
GLUT2 was detected by Western blot. B: auto-
radiograms corresponding to GLUT2 protein
content in liver extracts, hepatocytes, and PMs
from wild-type and PTP1B/ neonates were
quantitated by scanning densitometry. Results
are expressed as fold change of GLUT2 protein
content compared with the wild-type condition,
which was arbitrarily assigned a value of 1, and
are means  SE. Statistical significance was
carried out by Student’s t-test comparing
PTP1B/ primary hepatocytes, and PMs and
total extracts from livers of neonatal mice with
the respective values of wild-type controls.
*P  0.05 was considered significant. C, top:
RNA was isolated from livers of PTP1B/ and
PTP1B/ neonatal mice, and GLUT2 mRNA
levels were determined by Northern blot. Bot-
tom: GLUT2 mRNA levels were determined by
real-time PCR as described in MATERIALS AND
METHODS. Results are expressed as fold change
of mRNA compared with the wild-type condi-
tion, which was arbitrarily assigned a value of 1,
and are means  SE from 3 independent exper-
iments.
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increase in basal glucose uptake in neonatal PTP1B/ hepa-
tocytes. For this goal, we prepared liver extracts from wild-
type and PTP1B-deficient neonates, and enzymatic activities
were measured in the cytosolic and microsomal fractions,
respectively. Neither HK nor G6Pase activities were signifi-
cantly different between neonatal wild-type and PTP1B-defi-
cient livers (Table 1). Notably, in agreement with the similar
expression of GK in PTP1B/ and PTP1B/ adult hepato-
cytes, GK enzymatic activity did not change in adult
PTP1B/ livers compared with the wild-type. Together these
data reinforce the notion that the increase in glucose uptake in
PTP1B-deficient neonatal hepatocytes is not affected by changes
in the rate of glucose phosphorylation/dephosphorylation. To
investigate whether the increase in glucose uptake in PTP1B-
deficient neonatal hepatocytes reflects intracellular changes in
glucose levels in neonatal liver, we measured the net free
intrahepatic glucose. As shown in Table 1, the net free intra-
hepatic glucose was significantly higher in livers from neona-
tal, but not adult, PTP1B-deficient mice compared with their
respective wild-type controls. Although contamination of
blood glucose could be present in the assay used to determine
intrahepatic glucose on freeze-clamped livers, the results pre-
sented here are the means of 10–12 independent determina-
tions for each genotype, and we can assume that the degree of
possible contamination effects would be similar in both geno-
types.
The lack of PTP1B in neonatal hepatocytes increased the
ratio of IRA/IRB isoforms in neonatal, but not in adult, hepa-
tocytes. We have previously shown that glucose uptake in
neonatal hepatocytes expressing IRA isoform is higher than in
those cells expressing IRB (28). Accordingly, our next goal
was to investigate whether the changes in glucose uptake in
PTP1B/ neonatal vs. adult hepatocytes correlated with al-
terations in the profile of IR isoforms (IRA - exon 11 and
IRB  exon 11). As shown in Fig. 3A, primary hepatocytes
from adult wild-type mice expressed only IRB mRNA. These
results agree with those published by Giddings and Carnaghi
(17) examining rat liver mRNA levels. Interestingly, the lack
of PTP1B in adult hepatocytes did not change the profile of IR
isoforms. At the protein level, similar expression of IRB was
found in wild-type and PTP1B/ adult hepatocytes (Fig. 3B).
Conversely, wild-type neonatal hepatocytes expressed both
isoforms, IRB mRNA levels being nearly twofold higher than
IRA mRNA (Fig. 4A). Moreover, the lack of PTP1B in neo-
natal hepatocytes increased the IRA/IRB ratio by doubling the
amount of IRA mRNA in parallel with a 50% decrease in IRB
mRNA. At the protein level, IRB was analyzed by immuno-
precipitation of total cell lysates from wild-type and PTP1B/
immortalized neonatal hepatocytes with a specific anti-IRB
antibody (38). The resulting immune complexes were then
analyzed by Western blot with the anti-IR antibody. As shown
in Fig. 4B, IRB decreased by 60% in PTP1B/ neonatal
hepatocytes compared with the wild-type controls. The expres-
sion of IRA was analyzed by immunoprecipitation of the cell
lysates depleted of IRB with the anti-IR antibody. Figure 4B
shows a twofold increase in IRA expression in neonatal hepa-
tocytes lacking PTP1B. Since a specific anti-IRB antibody for
immunoblotting is not available, we cannot check that the
preclearing of IRB neonatal hepatocytes in wild-type and
PTP1B/ is 100% efficient, despite two rounds of immuno-
precipitation with the anti-IRB antibody having been per-
formed. However, our results clearly show a direct correlation
between the changes in the profile of IR isoforms at the mRNA
and protein levels. In addition, we performed a control exper-
iment by immunoprecipitating total cell lysates from neonatal
hepatocytes expressing only IRB isoform (HIR RecB) with the
anti-IRB antibody. The anti-IR Western blot revealed that at
least 90% of IRB was depleted (Fig. 4B, left).
The lack of PTP1B increased IRA/GLUT2 complexes in
immortalized neonatal hepatocytes and plasma membranes
from neonatal liver. The coimmunoprecipitation of IR and
GLUT2 has been reported in rat hepatocytes (12) and more
recently in immortalized neonatal hepatocytes (28). Further-
more, the lack of IR in neonatal hepatocytes resulted in a
significant decrease in basal glucose uptake, supporting the
hypothesis that IR and GLUT2 form a receptor-transporter
complex in hepatocytes. Importantly, the decrease in glucose
uptake in IR-deficient neonatal hepatocytes was reverted by
reexpressing the IRA isoform but not IRB (28). Since glucose
uptake is increased in PTP1B/ neonatal hepatocytes in
parallel with an increase in IRA isoform, we investigated the
possibility of changes in the association between IRA and
GLUT2. For that goal, cell lysates, obtained from growing
(10% FBS) wild-type and PTP1B/ immortalized hepato-
cytes, were depleted of IRB by two rounds of immunoprecipi-
tation with the specific anti-IRB antibody. The resulting cell
lysates were then reimmunoprecipitated with the anti-GLUT2
antibody, and the immune complexes were analyzed by West-
ern blot with the anti-IR antibody or with the anti-GLUT2
antibody. As shown in Fig. 5A, IRA associated GLUT2 with a
significant increase in PTP1B/ neonatal hepatocytes com-
pared with the wild-type controls. Importantly, the graph de-
picted in Fig. 5A shows the quantification of the IRA/GLUT2
complexes in neonatal hepatocytes after normalization with the
Table 1. Effect of PTP1B deficiency on HK, GK, and G6Pase enzymatic activities and net free intrahepatic glucose in livers
of wild-type and PTP1B-deficient mice
Neonatal Liver Adult Liver
PTP1B/ PTP1B/ PTP1B/ PTP1B/
Free hepatic glucose, mg/g 0.300.04 0.700.07* 2.370.09 2.060.15
Glucokinase, nmol  min1  mg protein1 — — 1.060.11 0.980.0.7
Hexokinase, nmol  min1  mg protein1 1.580.27 1.530.22 — —
G6Pase, nmol  min1  mg protein1 40.00.53 35.23.0 88.36.4 86.04.8
Values are means  SE. Hexokinase (HK) and glucokinase (GK) enzymatic activities were measured in cytosolic extracts from 10-12 livers of neonatal and
adult wild-type and protein tyrosine phosphatase 1B (PTP1B)/ mice as described in MATERIALS AND METHODS. Glucose 6-phosphatase (G6Pase) activity was
measured in the microsomal fraction. Net free intrahepatic glucose was measured as described in MATERIALS AND METHODS. Statistical significance was carried
out by Student’s t-test by comparison of wild-type and PTP1B/ livers. *P  0.05 was considered significant.
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amount of GLUT2 levels in the same immunoprecipitation. To
confirm these results, the same experiment was performed with
plasma membrane extracts prepared from pools of livers from
3–5-day-old wild-type and PTP1B-deficient mice. Of note,
IRA/GLUT2 complexes, normalized with the amount of GLUT2,
were more abundant in the plasma membrane fraction of
neonatal livers lacking PTP1B compared with the wild-type
controls.
To further demonstrate whether the increase in IRA led to
more abundance of IRA/GLUT2 complexes in PTP1B-defi-
cient neonatal hepatocytes, these cells were infected with
retroviruses encoding human IRA (PTP1B/IRA). As a con-
trol, immortalized PTP1B/ cells were infected with empty
vector (PTP1B/Hygro). The presence of human IRA in
immortalized PTP1B/IRA neonatal hepatocytes was as-
sessed by RT-PCR (Fig. 5B). Importantly, the endogenous
mouse IR isoforms remained unchanged in PTP1B/IRA
and PTP1B/Hygro cell lines compared with the parental
(PTP1B/) cell line. At the protein level, in PTP1B/IRA
cells, IR increased twofold compared with cells infected
with empty vector. However, as depicted in Fig. 5B, the
endogenous expression of GLUT2 remained unchanged.
Next, we performed the two-round immunoprecipitation
protocol described in Fig. 5A to measure IRA/GLUT2 com-
plexes normalized by the amount of GLUT2. Figure 5C
shows that, despite similar GLUT2 content in the immunopre-
cipitation, IRA/GLUT2 complexes significantly increased in
PTP1B/ neonatal hepatocytes overexpressing IRA com-
pared with those present in PTP1B-deficient cells infected with
empty vector.
DISCUSSION
The liver plays a major role in insulin-regulated glucose
homoeostasis through the balance and coordination of NHGU
and HGP. Classically, the HGP-suppressing effect of insulin is
thought to occur via hepatic IR signaling inhibiting glycogen-
olysis and gluconeogenesis. However, during the last years
several studies have challenged this paradigm strongly, sug-
gesting direct and indirect effects of insulin on the control of
HGP in the liver (19). By contrast, the contribution of the liver
to glucose utilization has been examined less thoroughly.
Insulin signaling is negatively regulated by several mecha-
nisms including downregulation of the IR, serine phosphory-
lation or degradation of IRS proteins, and IR and IRS dephos-
phorylation by specific PTPs (43). Of the latter, PTP1B has
been extensively studied in recent years as a therapeutic target
for type 2 diabetes and obesity. The liver is a major site of
PTP1B action in the periphery (10, 11). In fact, liver-specific
PTP1B reexpression in PTP1B-deficient mice attenuates the
increased insulin signaling and insulin hypersensitivity char-
acteristic of PTP1B/ animals (22). Euglycemic/hyperinsu-
linemic clamp studies in PTP1B-deficient mice revealed that
glucose utilization is increased compared with wild-type con-
trols. This was accompanied by significant increases in whole
body glycolysis and nonoxidative glucose metabolism (25).
However, since most of the glucose disposal during a euglycemic/
hyperinsulinemic clamp represents uptake into skeletal muscle,
the markedly increased glucose utilization in PTP1B/ mice,
compared with control mice, does not illustrate whether
PTP1B deficiency affects hepatic glucose utilization. To assess
this important issue, we have investigated the effect of PTP1B
deficiency in hepatic glucose uptake. We have measured in
vitro basal glucose uptake in primary wild-type and PTP1B-
deficient hepatocytes from 3–5-day-old neonatal mice and
10–12-wk-old adults representing two distinct stages of post-
natal development. The reason for this is the differential effect
of PTP1B deficiency in neonatal vs. adult hepatocytes. As we
have recently reported, in contrast to the increased insulin
Fig. 3. Expression profile of insulin receptor (IR) isoforms in adult wild-type
and PTP1B-deficient hepatocytes. A, top: total RNA was isolated from adult
primary hepatocytes from each genotype, and RT-PCR was performed as
described in MATERIALS AND METHODS. IR-deficient neonatal hepatocytes re-
constituted with IRA (IRA control) or IRB (IRB control) were used as controls.
As a loading control RT-PCR with mouse -actin primers has been performed.
A representative experiment is shown (bottom). The graph showing IRB
mRNA levels from 3 independent experiments were quantitated by scanning
densitometry and are expressed as fold change of PTP1B/ hepatocytes as
compared with the wild-type condition, which was arbitrarily assigned a value
of 1, and are means  SE. B: cell lysates from adult primary hepatocytes of
each genotype were analyzed by SDS-PAGE followed by Western blot with
antibodies against IR, PTP1B, and -actin as a loading control. A representa-
tive experiment is shown.
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signaling in adult PTP1B-deficient livers (13, 22) and hepato-
cytes (20), the lack of PTP1B in neonatal hepatocytes pro-
longed insulin signaling and insulin action without increasing
insulin sensitivity (20). On this basis, we wanted to know
whether the effect of PTP1B deficiency in basal glucose uptake
in hepatocytes varies in a postnatal developmental manner.
Our results clearly show that the positive effect of PTP1B
deficiency in basal glucose uptake in hepatocytes occurs only
in the neonatal state. This period is characterized by a marked
hypoinsulinemia and, consequently, very limited insulin-in-
duced glucose consumption by extrahepatic tissues (18). Nev-
ertheless, in hepatocytes glucose uptake is not regulated by
translocation of the glucose transporter GLUT2 from intracel-
lular stores to plasma membrane in response to insulin (27, 30).
By contrast, expression of GK in hepatocytes and pancreatic
-cells is of major physiological importance to mammalian
glucose homeostasis. Hepatic GK catalyzes the first committed
rate-limiting step in the disposal of glucose. Importantly, in
hepatocytes from suckling mice, the expression of GK, which
is induced by insulin after weaning, is absent. Of note, at this
postnatal stage, constitutively expressed HK is the main en-
zyme responsible for glucose phosphorylation (5, 34). In neo-
natal hepatocytes lacking PTP1B, insulin signaling and insulin
action are prolonged but not enhanced (20). Accordingly,
possible effects of PTP1B deficiency on insulin-induced gene
expression in these cells can be excluded as a mechanism
responsible for the increase in glucose uptake. Paradoxically,
our results show that PTP1B deficiency in adult hepatocytes,
which resulted in increased insulin signaling (20), did not
increase GK expression and/or activity. These results indicate
the existence of compensatory mechanisms, possibly mediated
through other PTPs, maintaining unaltered GK expression and,
Fig. 4. The lack of PTP1B in neonatal hepatocytes
increased the ratio of IRA/IRB isoforms. A: total RNA
was isolated from neonatal primary hepatocytes from
each genotype, and RT-PCR was performed as de-
scribed in MATERIALS AND METHODS. IR-deficient im-
mortalized neonatal hepatocytes reconstituted with IRA
or IRB were used as controls. As a loading control
RT-PCR with mouse -actin primers has been per-
formed. A representative experiment is shown. The
photos showing IRA and IRB mRNA expression from 5
independent experiments were quantitated by scanning
densitometry, and IRA/IRB ratio was calculated. Re-
sults corresponding to IRA and IRB mRNA levels are
expressed as arbitrary units. Results corresponding to
IRA/IRB ratio are expressed as fold change of
PTP1B/ hepatocytes compared with the wild-type
condition and are means  SE. Statistical significance
was carried out by Student’s t-test by comparison of
wild-type and PTP1B/ neonatal primary hepatocytes.
*P  0.05 was considered significant. B, left: total
protein (1 mg) from neonatal immortalized hepatocyte
cell lines (whole cell lysates) was immunoprecipitated
with the anti-IRB antibody. Then protein A agarose was
added for 2 h to collect the IRB immune complexes.
The supernatant (depleted of IRB) was reimmunopre-
cipitated with the anti-IRB antibody and, after that,
immunoprecipitated with the anti-IR antibody. The re-
sulting immune complexes and the IRB immune com-
plexes were analyzed by Western blot with the anti-IR
antibody. A fraction (50 g) of the whole lysates was
analyzed by Western blot with the anti--actin antibody
as a loading control. The photos showing IRA and IRB
isoforms protein expression from 5 independent exper-
iments were quantitated by scanning densitometry. Re-
sults are expressed as fold change of IR isoforms pro-
tein content in PTP1B/ neonatal hepatocytes com-
pared with the wild-type condition, which was
arbitrarily assigned a value of 1, and are means  SE.
Statistical significance was carried out by Student’s
t-test by comparison of wild-type and PTP1B/ neo-
natal primary hepatocytes. *P  0.05 was considered
significant. Right: cell lysates from immortalized neo-
natal hepatocytes expressing only IRB isoform (HIR
RecB) were immunoprecipitated with the anti-IRB
antibody. The resulting immune complexes were ana-
lyzed by Western blot with the anti-IR antibody. As a
loading control, a fraction (50 g) of the whole lysates
was analyzed by Western blot with the anti--actin
antibody. A representative experiment is shown.
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consequently, glucose uptake in adult hepatocytes in the ab-
sence of PTP1B.
Importantly, the net increase in basal glucose uptake in
PTP1B-deficient neonatal hepatocytes paralleled with an up-
regulation of GLUT2 at the protein level but without changes
in the expression of GLUT1. Since glucose metabolism is
required for the regulation of GLUT2 expression in the liver
(34), it is not possible to determine whether the increased
expression of GLUT2 in PTP1B/ neonatal hepatocytes is a
consequence of increased glucose uptake and, subsequently,
increased glucose metabolism or whether it is a direct/indirect
effect of the lack of PTP1B. The latter possibility agrees with
a role of PTP1B in the regulation of the expression of genes
involved in glucose or lipid metabolism in the liver. Regarding
this, Shimizu et al. (39) have reported that PTP1B activates
hepatic lipogenesis by increasing the expression of sterol
regulatory element-binding protein-1c, a mechanism mediated
by protein phosphatase 2A dephosphorylation and activation.
Moreover, since GLUT2 protein content is also increased in
the plasma membrane fraction, the possibility that PTP1B
deficiency can increase GLUT2 protein stability and/or cellular
distribution should not be excluded. Nevertheless, since the
transport capacity via GLUT2 is present in vast excess of the
GK trapping reaction in hepatocytes and, subsequently,
GLUT2 acts as a low-affinity, high-capacity transport system
to allow the uninhibited (non-rate-limiting) flux of glucose into
or out of hepatocytes (27, 30), the upregulation of GLUT2 in
neonatal PTP1B/ hepatocytes does not seem by itself to be
the molecular mechanism by which basal glucose uptake is
increased in these cells. Of note, under the same experimental
conditions (basal state), no differences in G6Pase enzymatic
activity were found between wild-type and PTP1B/ livers
from neonates. Moreover, basal glucose uptake was also in-
creased in PTP1B/ immortalized neonatal hepatocytes com-
pared with immortalized wild-type control. Importantly, both
kinds of immortalized neonatal hepatocytes do not express
Fig. 5. The lack of PTP1B increased the amount of
IRA/GLUT2 complexes in neonatal hepatocytes and
plasma membranes from neonatal liver. A: purified
fractions of liver plasma membranes from PTP1B/
and PTP1B/ neonatal mice were isolated as described
in MATERIALS AND METHODS. Total protein (1 mg) from
these purified fractions and from neonatal immortalized
hepatocyte cell lines (whole cell lysates) were immuno-
precipitated 2 times with the anti-IRB antibody. Then
protein A agarose was added for 2 h to collect the IRB
immune complexes. The supernatant (depleted of IRB)
was reimmunoprecipitated with the anti-GLUT2 anti-
body, and the resulting immune complexes were ana-
lyzed by Western blot with anti-IR and anti-GLUT2
antibodies. A representative experiment is shown. The
autoradiograms showing IRA-associated GLUT2 from
3 independent experiments were quantitated by scan-
ning densitometry. Results are expressed as fold in-
crease of IRA/GLUT2 association (normalized by the
amount of GLUT2) in PTP1B-deficient neonatal hepa-
tocytes and plasma membrane fractions compared with
the wild-type condition (set to 1) and are means  SE.
Statistical significance was carried out by Student’s
t-test by comparison between wild-type and PTP1B/
conditions. *P  0.05 was considered significant. B,
top: immortalized PTP1B/ neonatal hepatocytes were
infected with retroviruses encoding human IRA
(PTP1B/IRA). As a control, immortalized PTP1B/
cells were infected with empty vector (PTP1B/Hygro).
The presence of human IRA and the endogenous mouse
isoforms was assessed by RT-PCR. Bottom: the expres-
sion of IR and GLUT2 was analyzed by Western blot
with -actin as a loading control. *P  0.05 was
considered significant. C: total protein (1 mg) was
submitted to the 2-round immunoprecipitation protocol
described in A to measure IRA/GLUT2 complexes nor-
malized by the amount of GLUT2. The autoradiograms
showing IRA-associated GLUT2 from 3 independent
experiments were quantitated by scanning densitometry.
Results are expressed as fold increase of IRA/GLUT2
association in PTP1B/IRA cells compared with the
control condition (PTP1B/Hygro set to 1) and are
means  SE. Statistical significance was carried out by
Student’s t-test by comparison between PTP1B/IRA
and PTP1B/Hygro conditions. *P  0.05 was consid-
ered significant.
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phosphoenolpyruvate carboxykinase and G6Pase (results not
shown). This is an important issue since a higher accumulation
of 2-deoxyglucose in hepatocytes from PTP1B/ mice may
result from increased glucose uptake, decreased glucose re-
leased by the cell, or both. Accordingly, our results clearly
indicate that glucose uptake is increased in neonatal hepato-
cytes in the absence of PTP1B. More importantly, the increase
in basal glucose uptake of PTP1B/ neonatal hepatocytes
correlated with increased net free intrahepatic glucose content
in the livers from PTP1B-deficient neonates, indicating a
positive correlation of our results in vitro and in vivo.
Our previous results have demonstrated the involvement of
IR on basal glucose uptake in neonatal hepatocytes since
deletion of IR decreased basal glucose uptake by 50%. More
importantly, in IR-deficient neonatal hepatocytes, glucose up-
take was restored to similar levels as in control cells when IRA,
but not IRB, was reexpressed (28). These results, together with
those discussed below, suggest the importance of the expres-
sion ratios of IR isoforms during normal development or in the
pathogenesis of human diseases such as type 2 diabetes and
cancer. However, many of the studies on the relative expres-
sion of IRA and IRB isoforms in type 2 diabetes have reported
conflicting results. Several studies indicate that the expression
of IRB is increased in skeletal muscle or adipocytes of type 2
diabetic patients relative to control subjects (24, 36). By
contrast, Norgren et al. (29) reported an increase in the relative
abundance of IRA in the skeletal muscle of a patient with type
2 diabetes with markedly impaired insulin-mediated glucose
utilization. Furthermore, other groups have reported no differ-
ences in the relative amounts of IR isoforms in skeletal muscle
among lean normal, obese nondiabetic, and type 2 diabetic
subjects (2, 3). However, numerous studies have shown that
there is a preferential expression of IRA in fetal tissues such as
the kidney, muscle, and liver, as well as in many types of
cancer (reviewed in 37, 11). Concurring with this, in our study
we have demonstrated increased IRA, decreased IRB, and,
consequently, increased IRA/IRB ratio in neonatal hepatocytes
lacking PTP1B. In PTP1B/ neonatal hepatocytes, the in-
creased glucose uptake correlates with the upregulation of
IRA. By contrast, hepatocytes from adult mice lack IRA, IRB
being the isoform expressed at this stage of development.
Moreover, in these cells the lack of PTP1B did not modify the
profile of IR isoforms and, subsequently, glucose uptake re-
mained unchanged compared with wild-type cells. Thus our
data demonstrate a novel role of PTP1B in regulating the
expression of IR isoforms in neonatal hepatocytes and further
reinforce the suggested differential role of IR isoforms in
glucose transport. Moreover, our results show an increase in
IRA/GLUT2 complexes in PTP1B/ neonatal hepatocytes,
resulting in a more efficient role of IR to form a receptor-
transporter complex with GLUT2. Indeed, the amount of these
complexes augmented by IRA overexpression in PTP1B-defi-
cient cells. More importantly, the increased abundance of
IRA/GLUT2 complexes in PTP1B/ neonatal hepatocytes
compared with wild-type cells was significant after the nor-
malization for GLUT2 levels in the immunoprecipitation. This
result is particularly interestingly since it is the first evidence
that shows a direct correlation between increases in IRA/
GLUT2 complexes and glucose uptake. Furthermore, as dis-
cussed above, in IR-deficient neonatal hepatocytes, glucose
uptake, which was decreased compared with cells expressing
IR, was restored after reconstitution with IRA but not IRB (28).
Notably, because hepatocytes from adult mice only expressed
IRB, the association of IRA/GLUT2 cannot play a role in
glucose uptake at this developmental stage. It is intriguing why
this regulatory mechanism for glucose uptake operates in
neonatal, but not adult, hepatocytes. A possible explanation
that might account for this differential regulation is the fact that
neonatal liver is a growing tissue with higher mitogenic capac-
ity than the adult liver. Since growth factor receptors such as
EGF-R or IGF-I-R are PTP1B substrates (21), one would
expect that PTP1B deficiency increases the proliferative capac-
ity of liver cells and, subsequently, the requirements of glucose
uptake. The fact that PTP1B/ hepatocytes have increased
IRA, together with our previous results showing increased
IRS-1 (20), is consistent with this idea. Moreover, since the
regulation of hepatic metabolism differs between neonatal and
adult liver, current investigations are focused on the physio-
logical role of increased free glucose and glucose utilization in
PTP1B-deficient neonatal vs. adult livers.
In summary, results presented here demonstrate that deletion
of PTP1B markedly increased glucose uptake in neonatal, but
not adult, hepatocytes. GLUT2 is upregulated in PTP1B/
neonatal hepatocytes at the protein level. Moreover, PTP1B
deficiency alters the ratio of IRA/IRB isoforms by increasing
IRA isoform and decreasing IRB, resulting in a more abun-
dance of IRA/GLUT2 complexes. Thus the amount of IRA/
GLUT2 complexes plays a direct role in the regulation of
glucose uptake in neonatal hepatocytes. Consistent with this,
neonatal PTP1B/ hepatocytes might represent a suitable
model in which to study the role of IR isoforms in glucose
metabolism.
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